Moderna Says Its Norovirus Vaccine Missed an Early Success Threshold, and the Trial Will Continue

Moderna’s norovirus vaccine did not meet interim success criteria in phase 3. The trial continues blinded with a new cohort. Here is what that means.

Have A Referral?